Next Article in Journal
Application of Twin Screw Extrusion in the Manufacture of Cocrystals, Part I: Four Case Studies
Next Article in Special Issue
Recrystallization of Commercial Carbamazepine Samples—A Strategy to Control Dissolution Variability
Previous Article in Journal
The Application of Microencapsulation Techniques in the Treatment of Endodontic and Periodontal Diseases
Article Menu

Export Article

Open AccessArticle
Pharmaceutics 2011, 3(3), 572-581; doi:10.3390/pharmaceutics3030572

Development and Validation of a Microbiological Agar Assay for Determination of Orbifloxacin in Pharmaceutical Preparations

Programa de Pós-graduação em Ciências Farmacêuticas, Faculdade de Ciências Farmacêuticas, Univ Estadual Paulista, Rod. Araraquara-Jaú, km 1, CEP 14801-902,Araraquara, SP, Brazil
*
Author to whom correspondence should be addressed.
Received: 23 June 2011 / Revised: 9 August 2011 / Accepted: 25 August 2011 / Published: 29 August 2011
(This article belongs to the Special Issue Solid Dosage Forms)
View Full-Text   |   Download PDF [165 KB, uploaded 29 August 2011]   |  

Abstract

Orbifloxacin is a fluoroquinolone with broad-spectrum antimicrobial activity, and belongs to the third generation of quinolones. Regarding the quality control of medicines, a validated microbiological assay for determination of orbifloxacin in pharmaceutical formulations has not as yet been reported. For this purpose, this paper reports the development and validation of a simple, sensitive, accurate and reproducible agar diffusion method to quantify orbifloxacin in tablet formulations. The assay is based on the inhibitory effect of orbifloxacin upon the strain of Staphylococcus aureus ATCC 25923 used as test microorganism. The results were treated statistically by analysis of variance and were found to be linear (r = 0.9992) in the selected range of 16.0–64.0 μg/mL, precise with relative standard deviation (RSD) of repeatability intraday = 2.88%, intermediate precision RSD = 3.33%, and accurate (100.31%). The results demonstrated the validity of the proposed bioassay, which allows reliable orbifloxacin quantitation in pharmaceutical samples and therefore can be used as a useful alternative methodology for the routine quality control of this medicine. View Full-Text
Keywords: orbifloxacin; fluoroquinolones; bioassay; validation orbifloxacin; fluoroquinolones; bioassay; validation
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Cazedey, E.C.L.; Salgado, H.R.N. Development and Validation of a Microbiological Agar Assay for Determination of Orbifloxacin in Pharmaceutical Preparations. Pharmaceutics 2011, 3, 572-581.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top